Tumorigenicity and Organization of the Terminal Region of the Epstein-Barr Virus (EBV) Genome in LCLs Derived from Carcinogen-Treated Lymphocytes

  • Earl E. Henderson
  • Gerald Fronko
Part of the Experimental Biology and Medicine book series (EBAM, volume 24)


It has been proposed that uncontrolled EBV replication in the oral pharyngeal region is critical for the development of EBVassociated tumors. From epidemiological studies it seems certain that environmental cofactors contribute to the development of nasopharyngeal carcinoma (NPC). The recent discovery of carcinogen-inducible transcripts under the regulation of DNA damage-responsive elements provides a model to explain how DNA damage could influence viral expression and viral DNA replication (1–3). We propose that virus expression and viral DNA replication could be influenced by exposure to chemical or physical carcinogens through DNA damage-induced chromosomal decondensation followed by the direct interaction of carcinogen-inducible trans -acting factors with viral sequences homologous to DNA damage-responsive elements within the viral genome. Exposure to environmental carcinogens could result in the circumvention of normally stringent control of viral gene expression and lead to uncontrolled viral replication. These phenomena would account for an increase in tumors in populations exposed to viruses and environmental carcinogens.


Terminal Repeat Viral Gene Expression Viral Expression Environmental Carcinogen BamH1 Fragment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    S. Brunet, P.U. Giacomoni Mutat. Res. 219, 217 (1989).PubMedCrossRefGoogle Scholar
  2. 2.
    A.J. Fornace et al., Mol. Cell. Biol. 9, 4196 (1989).PubMedGoogle Scholar
  3. 3.
    S. Gibbs, F. Lohman et al., Nucleic Acids Res. 18, 4401 (1990).PubMedCrossRefGoogle Scholar
  4. 4.
    E.E. Henderson, J. Natl. Cancer Inst. 80, 476 (1988).PubMedCrossRefGoogle Scholar
  5. 5.
    I.H. Gelman, S. SilversteinJ. Virol. 61, 2286 (1987).PubMedGoogle Scholar
  6. 6.
    N. Raab-Traub, K. Flynn, Cell 47, 883 (1986).PubMedCrossRefGoogle Scholar
  7. 7.
    E.E. Henderson, C. Franks, J. Fronko, Int. J. Cancer 43, 72 (1989)CrossRefGoogle Scholar
  8. 8.
    G. Laux, M. Perricaudet et al., EMBO J. 7, 769 (1988).PubMedGoogle Scholar
  9. 9.
    D.T. Rowe et al., J. Virol. 64, 2866 (1990).PubMedGoogle Scholar
  10. 10.
    S. Karlin, Proc. Natl. Acad. Sci. USA 83, 6915 (1986).PubMedCrossRefGoogle Scholar
  11. 11.
    M. Durante et al., Carcinogenesis 10, 1357 (1989).PubMedCrossRefGoogle Scholar
  12. 12.
    W.B. Mattes et al., Carcinogenesis 9, 2065 (1988).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Earl E. Henderson
    • 1
  • Gerald Fronko
    • 1
  1. 1.Department of Microbiology and Immunology, and the Fels Institute for Cancer Research and Molecular BiologyTemple University School of MedicinePhiladelphiaUSA

Personalised recommendations